Core-004
Core-004
批准号:
10198073
负责人:
David H Ellison
金额:
$70.08万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-09-02 至 2022-08-30
关键词:
AchievementAreaBiometryClinical ResearchComplexConsultationsData AnalysesDevelopmentEnsureFosteringFundingGoalsHealthInfrastructureInstitutionInterventionKnowledgeMeasuresMethodologyMissionOregonProcessReportingResearch DesignResearch EthicsResearch InstituteResearch MethodologyResource SharingServicesSystemTimeTrainingTranslatingTranslational ResearchUniversitiesdesignepidemiology studyexperienceflexibilityhuman subject protectionimprovedinnovationprogramssuccess
中文摘要
研究方法部分由两个部分组成,重点是规划、实施和
在OHSU和合作机构实施高质量的临床和转化研究(CTR):
生物统计学、流行病学和研究设计(BERD)以及监管知识和支持(RKS)。在……里面
OCTRI 2.0,每个组成部分都有明确的目标,并伴随着相关的具体目标
实现这些目标。所有研究方法的目标都与OCTRI的总体目标很好地一致;
将衡量和评价每个单元对实现这些目标的贡献。两者都有
各构成部分利用OCTRI以往供资周期取得的成就,并利用下列活动
对OHSU基础设施(特别是生物统计和设计计划)至关重要的成功单位
[BDP]和临床研究办公室),以确保高效和及时地实现目标。
近年来,应对CTR挑战取得了长足的进步;然而,对复杂结构的研究
系统需要创新的方法和流程来有效和高效地将发现转化为
转变为改善健康的干预措施。反恐审查的成功离不开下列方面的考虑
研究伦理、研究设计、数据分析和解释。因此,专门用于规划的核心,
在OHSU实施高质量的CTR是实现总体目标的关键
OCTRI 2.0的目标。应对国际移民组织报告中提出的推动CTR创新的挑战,
OCTRI的生物统计学、流行病学和研究设计部分(OCTRI-BERD)提出了倡议
旨在促进方法发展,提供灵活的个性化培训体验,以及
促进BERD从业者的专业发展。此外,OCTRI-BERD将进一步增强
通过我们的生物统计大学共享提供协作和咨询服务
资源、生物统计与设计课程。监管知识和支持部分建议
旨在提供监管咨询服务的举措,培训工作人员
保护,并缓解CTR中与监管相关的瓶颈。这些努力将推动八达通社的任务
并在区域和整个CTSA网络中催化CTR。
英文摘要
The Research Methods section comprises two components focused on planning, operationalizing, and
implementing high quality Clinical and Translational Research (CTR) at OHSU and partnering institutions:
Biostatistics, Epidemiology and Research Design (BERD), and Regulatory Knowledge and support (RKS). In
OCTRI 2.0, each of these components has well-articulated goals, accompanied by relevant specific aims to
accomplish those goals. All the Research Methods aims are well aligned with the overarching aims for OCTRI;
contributions for each of the modules toward achievement of those aims will be measured and evaluated. Both
components capitalize on achievements in the prior OCTRI funding cycles, and leverage activities of
successful units that are essential to the OHSU infrastructure (in particular the Biostatistics & Design Program
[BDP] and the Office of Clinical Research), to ensure efficient and timely progress toward goals.
In recent years, great strides have been made tackling CTR challenges; however, the studies of complex
systems requires innovative methodologies and processes to effectively and efficiently translate discoveries
into interventions to improve health. Indispensable to the success of CTR are considerations in the areas of
research ethics, study design, data analyses, and interpretation. Thus, Cores dedicated to planning,
operationalizing, and implementing high quality CTR at OHSU are essential for achieving the overarching
goals of OCTRI 2.0. Responding to the challenges put forth in the IOM report to drive innovation in CTR,
OCTRI’s Biostatistics, Epidemiology and Research Design component (OCTRI-BERD) proposes initiatives
aimed at fostering methodology development, providing flexible personalized training experiences, and
promoting professional development of BERD practitioners. In addition, OCTRI-BERD will further enhance the
provision of collaborative and consultative services offered through our Biostatistics University Shared
Resource, Biostatistics & Design Program. The Regulatory Knowledge and Support component proposes
initiatives aimed at delivery of regulatory consultations services, training the workforce in human subjects’
protections, and alleviating regulatory-related bottlenecks in CTR. These efforts will further OCTRI’s missions
and catalyze CTR regionally and throughout the CTSA network.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Core-003
-
批准号:10198072
-
项目类别:
-
资助金额:$93.68万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Admin-Core-001
-
批准号:10198069
-
项目类别:
-
资助金额:$90.49万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Oregon Clinical and Translational Research Institute Quality Assurance and Quality Control Project
-
批准号:10158949
-
项目类别:
-
资助金额:$14.93万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Oregon Clinical and Translational Research Institute
-
批准号:10198068
-
项目类别:
-
资助金额:$630.8万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Oregon Clinical and Translational Research Institute
-
批准号:10693308
-
项目类别:
-
资助金额:$967.3万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Core-005
-
批准号:10198074
-
项目类别:
-
资助金额:$164.5万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Oregon Clinical and Translational Research Institute
-
批准号:9514362
-
项目类别:
-
资助金额:$616.99万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Oregon Clinical and Translational Research Institute - The National COVID Cohort Collaborative (N3C)
-
批准号:10179888
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Core-001
-
批准号:10198070
-
项目类别:
-
资助金额:$68.71万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Core-002
-
批准号:10198071
-
项目类别:
-
资助金额:$41.36万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Oregon Clinical and Translational Research Institute - Evaluation of OCTRI's Response to COVID-19
-
批准号:10158990
-
项目类别:
-
资助金额:$9.35万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Core-007
-
批准号:10198076
-
项目类别:
-
资助金额:$36.75万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Core-006
-
批准号:10198075
-
项目类别:
-
资助金额:$65.22万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Oregon Clinical and Translational Research Institute
-
批准号:10675189
-
项目类别:
-
资助金额:$967.3万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Oregon Clinical and Translational Research Institute
-
批准号:9977301
-
项目类别:
-
资助金额:$633.75万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Oregon Clinical and Translational Research Institute
-
批准号:9816556
-
项目类别:
-
资助金额:$17.88万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Renal Effects of Aldosterone
-
批准号:10266000
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:David H Ellison
-
依托单位:
Renal and extrarenal toxicity of aldosterone
-
批准号:9280815
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:David H Ellison
-
依托单位:
Renal and extrarenal toxicity of aldosterone
-
批准号:8635009
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:David H Ellison
-
依托单位:
Molecular pathogenesis of calcineurin inhibitor-induced hypertension
-
批准号:8549218
-
项目类别:
-
资助金额:$35.68万
-
财政年份:2012
-
负责人:David H Ellison
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: